A Practice Note discussing when to report a patent or trademark license transaction under the Hart-Scott-Rodino (HSR) Act. This Note discusses how to determine if a license is exclusive, the HSR rules for acquisitions of pharmaceutical patent licenses, including options and terminations, non-pharmaceutical patent licenses, and trademark licenses. This Practice Note also discusses how to value licenses to determine HSR reportability and applicable HSR exemptions.